University of Pavia

China's BNCT Cancer Treatment Breakthrough: Neuboron Medical Group Reports Success with First Domestic System

4 months ago

• Neuboron Medical Group has established China's first accelerator-based Boron Neutron Capture Therapy (BNCT) center, making China the second country globally to offer this advanced cancer treatment technology. • The company's NeuPEX Block-I system demonstrates superior performance metrics, including 11cm treatment depth and 40cm irradiation aperture, alongside innovative boron drugs with improved clinical characteristics. • Over three years of operation at Xiamen Humanity Hospital, the system has conducted more than 40 clinical trials and 50 irradiation treatments, validating its stability and reliability.